Drug Type Fab fragment |
Synonyms ABR 214936, ABR-214936, PNU 214936 + [2] |
Target |
Mechanism Tumor-associated glycoprotein 72 inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Anatumomab mafenatox | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Kidney Neoplasms | Phase 2 | SE | - | |
Kidney Neoplasms | Phase 2 | GB | - | |
Non-Small Cell Lung Cancer | Phase 2 | US | - | |
Pancreatic Cancer | Phase 2 | GB | - | |
Renal Cell Carcinoma | Phase 2 | - | - |